Bullish
OMCL or HIMS: Which Is the Better Value Stock Right Now?
OMCL vs. HIMS: Which Stock Is the Better Value Option?
Recent News
Powered by Alpha Vantage
Bullish
Investors Heavily Search Hims & Hers Health, Inc. ( HIMS ) : Here is What You Need to Know
Hims & Hers Health (HIMS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Bullish
Hims & Hers Faces FDA Heat As Commissioner Martin Makary Calls Out Super Bowl Ad For Hiding Drug Risks - Hims & Hers Health ( NYSE:HIMS ) , Novo Nordisk ( NYSE:NVO )
Food and Drug Administration Commissioner Martin Makary stated on Friday that Hims & Hers Health Inc. HIMS broke federal law with its Super Bowl commercial promoting weight-loss drugs. Check out the current price of HIMS stock here.
Bullish
Hims & Hers Surges 64.1% in 6 Months: How to Play the Stock?
HIMS accelerates with new men's health launches, global expansion plans and strong subscriber-driven growth, but rising costs strain gross margins.
Bullish
Hims & Hers Health, Inc. ( HIMS ) Stock Drops Despite Market Gains: Important Facts to Note
In the latest trading session, Hims & Hers Health, Inc. (HIMS) closed at $47.79, marking a -3.73% move from the previous day.
Bullish
Hims & Hers Expanding Partnerships to Build a Global Health Ecosystem
HIMS expands its digital health footprint with global moves, top-tier partnerships and more than 1,500 providers.
Bullish
Here is What to Know Beyond Why Hims & Hers Health, Inc. ( HIMS ) is a Trending Stock
Hims & Hers Health (HIMS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Bullish
HIMS' Personalized Wellness Platform Expands Preventive Care Access
Hims & Hers expands its personalized wellness platform, aiming to reshape preventive care through tech-driven, holistic solutions.
AI Tools
Key Metrics
Trend: Range-Bound
As of 2025-09-10 (Snapshot)
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers with licensed healthcare professionals. The company is headquartered in San Francisco, California.
52W High
$72.98
52W Low
$13.70
MA Status:
50D: Below
200D: Above
Beta (~1 neutral, <0.9 lower risk)
2.14
Valuation
Rich
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
61.28
Forward P/E (<15 better)
62.89
EV/EBITDA (<8 favorable)
70.05
EV/Revenue (<3 favorable)
5.38
P/S (TTM) (<3 favorable)
5.43
P/B (<3 favorable)
19.45
Ownership
Institution‑heavySource: Overview
Insiders (1–5% typical)
10.63%
Institutions (25–75% balanced)
88.94%
Shares Outstanding
217,642,000
Float
197,566,000
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
2,013,538,000
Gross Profit (TTM)
1,534,312,000
EPS (TTM)
0.79
Profit Margin (>10% good)
0.10%
Operating Margin (TTM) (higher better)
0.05%
ROE (TTM) (>15% strong)
0.42%
EPS YoY (Quarterly) (>10% good)
1.98
Revenue YoY (Quarterly) (>8% good)
0.73
Momentum
Bearish momentumValue
-1.8527
Previous
-2.4066
Trend
Rising
Signal Cross
No cross
As of
Sep. 05, 2025